e8vk
 

TABLE OF CONTENTS

Item 2.02 Results of Operations and Financial Condition
SIGNATURE
EXHIBIT INDEX
SELECT MEDICAL CORPORATION PRESS RELEASE, DATED FEBRUARY 2, 2005

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 2, 2005

SELECT MEDICAL CORPORATION

(Exact name of registrant as specified in its charter)
         
Delaware
(State or other jurisdiction of
Incorporation) 		  000-32499
(Commission File
Number) 		  23-2872718
(I.R.S. Employer
Identification No.)

4716 Old Gettysburg Road, P.O. Box 2034, Mechanicsburg, PA 17055

(Address of principal executive offices) (Zip Code)

(717) 972-1100

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

Item 2.02 Results of Operations and Financial Condition.

          On February 2, 2005, Select Medical Corporation issued a press release reporting its results for the fourth quarter of 2004. A copy of the press release is attached as Exhibit 99.1 to this report.

          The information in this report (including Exhibit 99.1) is being furnished pursuant to Item 2.02 and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.

 

 

SIGNATURE

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

         
  SELECT MEDICAL CORPORATION
 		  
Date: February 2, 2005  By:   /s/ Michael E. Tarvin    
    Michael E. Tarvin   
    Senior Vice President, General Counsel and
Secretary 		  

 

 

         

EXHIBIT INDEX

     
Exhibit No.
  Description
 
   
 
99.1
  Select Medical Corporation press release, dated February 2, 2005.